Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prefuvir mesylate vs tenofovir disoproxil fumarate for chronic hepatitis B
ChiCTR2600117653Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prefuvir mesylate in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: HBV DNA negative conversion rate and Reduction in HBV DNA load. Started Jan 2026; status: recruiting.
02
Drugs
prefuvir mesylate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2600117653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117653.